Women's Health as Infrastructure - The Investment Case for the Most Under-Leveraged Growth Strategy in the Global Economy

Women's
Health
THE INVESTMENT CASE FOR THE MOST
UNDER-LEVERAGED GROWTH
STRATEGY IN THE GLOBAL ECONOMY.
as
Infrastructure
THE INVESTMENT CASE FOR THE MOST UNDER-LEVERAGED GROWTH STRATEGY IN THE GLOBAL ECONOMY.
TRUSTED BY
EXPERIENCE

From Engineering to Infrastructure

Marissa spent 25 years in medtech before writing the playbook on why women's health is infrastructure. She's led four venture-backed companies, raised capital globally, and navigated FDA clearance for an AI tool built to detect breast cancer in women with dense tissue.

Today she runs an AI diagnostics company, a global nonprofit, and sits on investment committees for funds focused on women's health, all built on the same thesis: women's health isn't a cause. It's infrastructure, and the returns on building it are massive.

Meet Marissa
EXPERTISE

How Marissa Works

Most people in women's health pick one lane. Marissa runs four at the same time because the work requires it, and what she learns in one changes how she operates in the others.
Building the Supply Chain That Doesn't Exist Yet

HERhealthEQ started with a broken mammography unit on the coast of Costa Rica and a question: why are women dying from something we already know how to detect?

Today the nonprofit has reached over 128,000 women in twelve countries, deploying medical devices and diagnostic equipment for cancers affecting women, maternal health complications, and cardiovascular disease.

The equipment isn't donated and forgotten. It's matched, serviced, and integrated into local health systems because Marissa runs her nonprofit the way she runs her companies: with accountability, service contracts, and a clear line between impact and operational sustainability.

Commercializing the Technology Others Said Was Too Niche

Marissa is CEO of DeepLook Medical, an AI diagnostics company that detects breast cancer earlier in women with dense breast tissue. She took DeepLook from concept through FDA clearance and into global commercialization. It's personal, too: Marissa has dense breast tissue herself. Before DeepLook, she spent over nine years at Hologic and a decade building a consulting firm focused on executive leadership, strategic growth, and commercialization for medtech and life science companies. She's held executive roles at companies of every size, and her conviction hasn't changed: the women's health market isn't small. It's just been systematically underestimated.

Putting the Thesis into Practice Where Decisions Get Made

Marissa works with medical device and life science companies around the world on commercialization strategy, M&A transactions, and growth planning. She also sits on the investment committee for funds focused on women's health globally, helping scale innovative technology from early-stage ventures through market entry.

She serves on the boards of several private companies and advises them toward growth in women's health and international markets. The advising work isn't separate from the rest. It's where the infrastructure argument meets the people writing the checks.

ON STAGE

The Talk That Changes the Room

Marissa doesn't give the kind of talk where everyone nods and then nothing happens. She shows up with 25 years of operational data, a boardroom-ready investment case, and the kind of bluntness that comes from having personally navigated the funding bias, the "market is too small" objections, and the institutional inertia that keeps women's health on the sidelines. Trusted by TEDx, the United Nations, and HLTH.
Book Marissa
The investment case and playbook for
treating Women's Health as Infrastructure.

Undervalued to Unavoidable

Every economic challenge on the table right now, from productivity stagnation and demographic decline to healthcare costs that won't stop climbing, traces back to the same structural underinvestment. That's true in New York and it's true in Nairobi. This book makes the case, provides the framework, and gives executives, investors, and board members across the global economy the playbook to act on it.
Preorder
“Women's health becomes infrastructure … If women don't have their health, the foundation crumbles.”
Let’s Talk Medtech
“Historically, women have been underrepresented in clinical trials, which led to poor health outcomes and huge data gaps. That’s why we need to keep talking about diversity, especially when it comes to AI. There’s no reason to stop talking about it.”
Femtech World
“Women need to be part of the tech movement and need to be equal partners in leadership, development, and all areas of the business. Without women in tech, there is no equality in tech.”
Women of Wearables
"As 51% of the population, women hold significant value in all sectors of the economy including consumer, industrial, and political."
MedCity News
Ready to start a conversation?
Reach out to discuss how Marissa can help your organization.
Contact Marissa